Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 32, 2002 - Issue 10
33
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration

, , , , , & show all
Pages 879-893 | Published online: 22 Sep 2008

References

  • BEAULIEU, E., DEMUELE, M., GHITESCU, L. and BELIVEAU, R., 1997, P-glycoprotein is strongly expressed in the luminal membranes ofthe endothekium of blood vessels in the brain. Biochemical Journal, 326, 539–544.
  • BEND, J. R., SERARPT-SINGH, C. E. and PHILOT, R. M., 1985, The pulmonary uptake, accumulation, and metabolism of xenobiotics. Annual Review of Pharmacology and Toxicology, 25, 97–125.
  • BROWN, E. A. B., 1974, The localization, metabolism and effects of drugs and toxicants in lung. Drug Metabolism Reviews, 3, 33–87.
  • DOLLERY, C. T. and JuNob, A. F., 1976, Concentration of (±)-propranolol in isolated, perfused lungs of rat. British Journal of Pharmacology, 57, 67–71.
  • DRESSER, M. J., DEARMAN, M. K. and GIACOMINI, K. M., 2001, Transporter involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. Journal of Pharmaceutical Sciences, 90, 397–421.
  • ELING, T. E., PICKETT, R. D., ORTON, T. C. and ANDERSON, M. W., 1975, A study of the dynamic of imipramine accumulation in the isolated perfused rabbit lung. Drug Metabolism and Disposition, 3, 389–399.
  • HACKMAN, C. R., ROSENGARD, S. and VAPPATOLO, H., 1970, Tissue distribution of chlorpromadine studied by microautoradiography. European Journal of Pharmacology, 9, 59–66.
  • HIGAKI, K., YuKAw.a, T., TAKEUCHI, M., NEZASA, K. and NAKANO, M., 1998, Stereoselective uptake of an organic anion across the renal basolateral membrane in isolated perfused rat kidney. Drug Metabolism and Disposition, 26, 138–145.
  • KEKUDA, R., PRASAD, P. D., Wu, X., WANG, H., FEI, Y. J., LEIBACH, F. H. and GANAPATHY, V., 1998, Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. Journal of Biological Chemistry, 273, 15971–15979.
  • KOHNO, Y., YOSHIDA, H., SUWA, T. and SUGA, T., 1989, Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. Antimicrobial Agents and Chemotherapy, 33, 751–756.
  • KOHNO, Y., YOSHIDA, H., SUWA, T. and SuGA, T., 1990, Uptake of clarithromycin by rat lung cells. Journal of Antimicrobial Chemotherapy, 26, 503–513.
  • KOHNO, Y., YOSHIDA, H., YOSHITOMI, S. and SUWA, T., 1988, Pharmacokinetics of TE-031 VII: its pulmonary disposition. Chemotherapy, 36, 257–263.
  • NAKAGAWA, Y., PrAi, S., YOSHIDA, T. and NAGAI, T., 1992, Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chemical and Pharmaceutical Bulletin, 40, 725–728.
  • NISHIDA, K., TONEGAWA, C., KAKUTANI, T., HASHIDA, M. and SEZAKI, H., 1989, Statistical moment analysis of hepatobiliary transport of phenol red in the perfused rat liver, Pharmaceutical Research, 6, 140–146.
  • NISHIURA, A., HIGAsiti, J., MURAKAMI, T., HIGAsm, Y. and YATA, N., 1986, A possible contribution of phospholipids in tissue distribution of quinidine in rats. Journal of Pharmacobio-Dynamics, 9, 819–828.
  • NISHIURA, A., MURAKAMI, T., HIGAsiti, Y. and YATA, N., 1987, Role of acidic phospholipids in tissue distribution of quinidine in rats. Journal of Pharmacobio-Dynamics, 10, 135–141.
  • OGAWARA, K., NISHIKAWA, M., TAKAKURA, Y. and HASHIDA, M., 1998, Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver. Journal of Controlled Release, 50, 309–317.
  • OKUMURA, K., YOSHIDA, H. and Horn, R., 1978, Tissue distribution and metabolism of drugs III accumulation of drugs by the isolated perfused rat lung. Journal of Pharmacobio-Dynamics, 1, 230–237.
  • OKUMURA, K., YOSHIDA, H., KAMIYA, A. and Horn, R., 1989, Mitochondrial distribution of basic drugs in the isolated perfused lung. Chemical and Pharmaceutical Bulletin, 37, 1109–1111.
  • POST, C., ANDERSON, R. G. G., RYRFELDT, A. and NILSSON, E., 1978, Transport and binding of lidocaine by lung slices and perfused lung of rats. Acta Pharmcologica et Toxicologica, 43, 156–163.
  • POSTI, J. and SALONEN, M., 1983, Effect of formulation factors and food intake on the bioavailability of erythromycin stearate tablets. International Journal of Pharmaceutics, 17, 225–235.
  • SAID, S. I., 1982, Pulmonary metabolism of prostaglandins and vasoactive peptides. Annual Review of Physiology, 44, 257–268.
  • SCHOMIG, E., SPITZENBERGER, F., ENGELHARDT, M., MARTEL, F., ORDING, N. and GRUNDEMANN, D., 1998, Molecular cloning and characterization of two novel transport proteins from rat kidney. FEBS Letters, 425, 79–86.
  • TAKANO, M., HASEGAWA, R., FUKUDA, T. YUMOTO, R., NAGAI, J. and MURAKAMI, T., 1998, Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. European Journal of Pharmacology, 358, 289–294.
  • TERASAKI, T., IGA, T., SUGIYAMA, Y. and HANANO, M., 1984, Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies of variation of tissue-to-plasma partition coefficients in rats. Journal of Pharmaceutical Sciences, 73, 1359–1363.
  • TSUJI, A., YOSHIKAWA, T., NISHIDE, K., MINAMI, H., KIMURA, M., NAKASHIMA, E., TERASAKI, T., MuLamom, E., NIGHTINGALE, C. H. and YAMANA, T., 1983, Physiologically based pharmacokinetic model for 0-lactam antibiotics. I: Tissue distribution and elimination in rats. Journal of Pharmaceutical Sciences, 72, 1239–1251.
  • ULLRICH, K. J., 1994, Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. Biochimica et Biophysica Acta, 1197, 45–62.
  • WAKASUGI, H., YANO, I., Pro, T., HASHIDA, T., FUTUMI, T., NOHARA, R., SASAYAMA, S. and INui, K., 1998, Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clinical Pharmacology and Therapeutics, 64, 123–128.
  • WU, X., HUANG, W., GANAPATHY, M. E., WANG, H., KEKUDA, R., CONWAY, S. J., LEIBACH, F. H. and GANAPATHY, V., 2000, Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. American Journal of Physiology, 279, F449–F458.
  • WU, X., PRASAD, P. D., LEIBACH, F. H. and GANAPATHY, V., 1998, cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochemical and Biophysical Research Communications, 246, 589–595.
  • YAMAOKA, K. and NAKAGAWA, T., 1983, A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. Journal of Pharmacobio-Dynamics, 6, 595–606.
  • YAMAZAKI, M., SUZUKI, H., HANANO, M., TOKUI, T., KOMAI, T. and SUGIYAMA, Y., 1993, N± - independent multispecific anion transporter mediates active transport of pravastatin into rat liver. American Journal of Physiology, 264, G36–G44.
  • YATA, N., TOYODA, T., MURAKAMI, T., NISHIURA, A. and HIGAsm, Y., 1990, Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs accumulated in the isolated perfused lung. Pharmaceutical Research, 7, 1019–1025.
  • YOSHIDA, H., OKUMURA, K. and Horn, R., 1987, Subcellular distribution of basic drugs accumulated in the isolated perfused lung. Pharmaceutical Research, 4, 50–53.
  • YOSHIDA, H., OKUMURA, K., KAMIYA, A. and Horn, R., 1989, Accumulation mechanism of basic drugs in the isolated perfused rat lung. Chemical and Pharmaceutical Bulletin, 37, 450–453.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.